Skip to main content
. 2022 Jan 4;80:11. doi: 10.1186/s13690-021-00713-1

Table 4.

Mortality rate stratified by selected socio demographic and clinical characteristics of TB/HIV co-infected children

Characteristics Total N PY Death N IDR
Age ≤1 18 (6.3) 75.66 1 1.32
1-5 78 (27.5) 426.33 10 2.34
6-10 136 (47.9) 590.58 20 3.38
11-15 52 (18.3) 164.58 4 2.43
Mother HIV status Positive 219 (77.1) 1028.08 32 3.11
Negative/unknown 65 (22.9) 229.08 3 1.3
Baseline WHO stage I & II 60 (21.1) 212 4 1.88
III & IV 224 (78.9) 1045.166 31 2.96
Baseline OI Yes 261 (91.9) 1200 32 2.67
No 23 (8.1) 57.16 3 5.24
Baseline HIV related immune suppression Non-significant/mild 172 (65.9) 800.167 8 9.99
Advanced 46 (16.1) 196.75 6 3.04
Sever 66 (18.1) 260.25 21 8.06
Hemoglobin level ≤10 104 (36.6) 455.91 27 5.92
> 10 180 (63.4) 801.2 8 0.99
Treatment Failure Yes 40 (14.1) 222 3 1.35
No 244 (85.9) 1035 32 3.09
IPT Yes 182 (64.1) 874 19 2.17
No 102 (35.9) 383.16 16 4.17
CPT Yes 260 (91.5) 11.83 33 2.8
No 24 (8.5) 81.3375 2 2.45
Adherence Good 266 (93.7) 1193.33 28 2.36
Fair/poor 18 (6.4) 63.83 7 10.96
Site of TB Pulmonary 218 (76.8) 1153.66 25 2.16
Extrapulmonary 66 (23.2) 103.5 10 9.66
TB drug Resistance No 264 (93) 1193.33 27 2.26
MDR 20 (7) 63.83 8 12.53

PY person year, IDR incidence density rate.